ML Cleary

9.5k total citations · 1 hit paper
49 papers, 7.5k citations indexed

About

ML Cleary is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, ML Cleary has authored 49 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 16 papers in Public Health, Environmental and Occupational Health and 15 papers in Molecular Biology. Recurrent topics in ML Cleary's work include Acute Lymphoblastic Leukemia research (15 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). ML Cleary is often cited by papers focused on Acute Lymphoblastic Leukemia research (15 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). ML Cleary collaborates with scholars based in United States and Canada. ML Cleary's co-authors include Brunangelo Falini, K C Gatter, Georges Delsol, Banks Pm, NL Harris, Chan Jk, H Stein, Chris Peeters, MP Link and SP Hunger and has published in prestigious journals such as Blood, Journal of Applied Physiology and Leukemia.

In The Last Decade

ML Cleary

49 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

1994 5.0k citations NL Harris, H Stein et al. Blood profile →

Peers

Countries citing papers authored by ML Cleary

Since Specialization

Citations

This map shows the geographic impact of ML Cleary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ML Cleary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ML Cleary more than expected).

Fields of papers citing papers by ML Cleary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ML Cleary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ML Cleary. The network helps show where ML Cleary may publish in the future.

Co-authorship network of co-authors of ML Cleary

This figure shows the co-authorship network connecting the top 25 collaborators of ML Cleary. A scholar is included among the top collaborators of ML Cleary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ML Cleary. ML Cleary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia 1997 ·Leukemia ·(unknown), Jeffrey E. Rubnitz, ML Cleary, LS Frankel, Nasrollah Hakami, MP Link, DJ Pullen, SP Hunger	7
2	The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties 1996 ·Blood ·SP Hunger, (unknown), (unknown), Louie Naumovski, ML Cleary	32
3	True histiocytic lymphoma following therapy for lymphoblastic neoplasms 1996 ·Blood ·Robert A. Soslow, R. E. Davis, RA Warnke, ML Cleary, (unknown)	26
4	A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments] breakdown → 1994 ·Blood ·NL Harris, (unknown), H Stein, Banks Pm, Chan Jk, ML Cleary, Georges Delsol, Chris Peeters, Brunangelo Falini, K C Gatter	4981
5	A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments] 1994 ·Blood ·NL Harris, ES Jaffe, (unknown), P. M. Banks, (unknown), ML Cleary, Georges Delsol, (unknown), Brunangelo Falini, K C Gatter	125
6	ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells 1994 ·Blood ·(unknown), Joseph J. Morrissey, (unknown), ML Cleary	5
7	The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma 1994 ·Blood ·(unknown), (unknown), Weiss Lm, Phil Huie, RA Warnke, ML Cleary	3
8	Bcl2 inhibits apoptosis associated with terminal differentiation of HL- 60 myeloid leukemia cells 1994 ·Blood ·Louie Naumovski, ML Cleary	14
9	Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study 1993 ·Blood ·MJ Borowitz, SP Hunger, AJ Carroll, JJ Shuster, DJ Pullen, CP Steuber, ML Cleary	1
10	A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias 1993 ·Blood ·Joseph J. Morrissey, (unknown), Athena Milatovich, (unknown), MP Link, ML Cleary	7
11	Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas 1989 ·Blood ·(unknown), Jamison L. Nourse, ML Cleary	206
12	Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis 1989 ·Blood ·R Morgan, SD Smith, (unknown), (unknown), (unknown), R Warnke, ML Cleary	84
13	Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis 1989 ·Blood ·R Morgan, SD Smith, (unknown), (unknown), (unknown), R Warnke, ML Cleary	1
14	Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus 1988 ·Blood ·ML Cleary, (unknown), William T. Shearer, Jeffrey Sklar	150
15	Idiotype as a tumor-specific marker in childhood B cell acute lymphoblastic leukemia 1988 ·Blood ·(unknown), MP Link, ML Cleary, Sheyla Batista Bologna, (unknown), MD Amylon, SD Smith, Ronald Levy	7
16	Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome 1985 ·Blood ·(unknown), (unknown), ML Cleary, (unknown), MP Link	23
17	Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome 1985 ·Blood ·R Morgan, Frederick Hecht, ML Cleary, Jeffrey Sklar, MP Link	38
18	Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genes 1985 ·Blood ·WM Crist, ML Cleary, CE Grossi, (unknown), (unknown), G A Omura, AJ Carroll, MP Link, (unknown)	4
19	Detection of two distinct malignant B cell clones in a single patient using anti-idiotype monoclonal antibodies and immunoglobulin gene rearrangement 1985 ·Blood ·(unknown), RW Schroff, (unknown), DW Golde, (unknown), ML Cleary, Jeffrey Sklar, (unknown), KA Foon	19
20	Immunoglobulin gene rearrangements in hairy cell leukemia 1984 ·Blood ·ML Cleary, GS Wood, R Warnke, (unknown), J Sklar	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact